10.30 am - "Revolutionising Stroke Rehabilitation"
Professor Cathy Stinear
In this presentation, Cathy Stinear will describe how hospitals are now using biomarkers to choose the right treatments and tailor rehabilitation for individual patients.
Professor Cathy Stinear is a clinical neuroscientist in the Department of Medicine. Her research focuses on developing tools to predict and promote recovery after stroke.
12.00 pm - "The Magic and Excitement of the Human Brain"
Sir Richard Faull, Distinguished Professor and Director of the Centre for Brain Research (CBR) will take the audience on a journey of discovery through the wonders and marvels of the human brain. He will highlight how the bequest of post-mortem human brains from families touched by neurological diseases has transformed research in the CBR and enabled researches to do world leading research which has the potential to develop new treatments for brain disease.
Distinguished Professor Sir Richard Faull has been Director of the Centre for Brain Research since its inception in 2009 creating one of the pre-eminent neuroscience research centres in Australasia. Sir Richard has spent 40 years studying neurodegenerative diseases of the human brain and his research achievements have been recognized by several awards including Fellow of the Royal Society of New Zealand, the award of New Zealand’s highest scientific award, the Rutherford Medal, and the Supreme Award in the 2010 World Class New Zealand Awards. He was appointed as a Knight Companion of the New Zealand Order of Merit (KNZM) for services to medical research in the 2017 New Year Honours.
1.30-2.30 pm - "Migraines and Headaches"
Professor Debbie Hay
This talk will explain what migraine is, how it affects people, and how badly-needed new treatments are emerging, which is based on the science behind a neuropeptide hormone (CGRP) that controls pain signals.
Debbie Hay is Professor, and a James Cook Fellow. Her research aims to contribute to the development of medicines to treat migraine, and other conditions. She studies the proteins that transmit CGRPs’ pain signals.